Nancy Reau, MD
Rush University Medical Center
Webcast must be viewed in its entirety to claim credit.
This activity is supported by an educational grant from AbbVie, Bristol-Myers Squibb and Salix.
This activity has been designed to meet the educational needs of gastroenterologists, nurse practitioners, physician assistants, nurses and pharmacists.
At the conclusion of this activity, participants will be able to:
Analyze presentations from the 2017 Liver Meeting® that provide new data on the treatment of hepatic encephalopathy
Discuss new data, presented at the 2017 Liver Meeting®, on modifiable risk factors for hepatic encephalopathy
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the Chronic Liver Disease Foundation (CLDF). The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.
The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 0.5AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The Annenberg Center for Health Sciences at Eisenhower is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
A maximum of 0.5 contact hours may be earned for successful completion of this activity.
ACPE Accreditation (Pharmacists):
The Annenberg Center for Health Sciences at Eisenhower is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program has been assigned ACPE Universal Program #0797-9999-17-117-H01-P. This program is designated for up to 0.5 contact hours (0.5 CEUs) of continuing pharmacy education credit.
Disclosure of Conflicts of Interest:
All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., John Bayliss, VP, Business Development, Annenberg Center, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower and Chronic Liver Disease Foundation (CLDF) have no relationships to disclose.
Learner Assurance Statement:
The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members' significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.
Nancy Reau, MD has received research support from Abbott, AbbVie, Gilead, Intercept and Shire. She is a consultant for AbbVie, Gilead and Merck.